Vivos Therapeutics (VVOS) Earnings Date, Estimates & Call Transcripts $2.06 -0.02 (-1.15%) As of 09:35 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vivos Therapeutics Earnings Summary Vivos Therapeutics posted Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.45, which missed analysts' consensus estimates of -$0.44 by $0.01. Quarterly revenue was reported to be $3.70 million, above analysts' expectations of $3.63 million. With a trailing EPS of -$1.73, Vivos Therapeutics' earnings are expected to grow next year, from ($1.79) to ($1.43) per share. Latest Q1 Earnings DateMay. 15EstimatedConsensus EPS (May. 15) -$0.44 Actual EPS (May. 15) -$0.45 Missed By -$0.01 Actual Revenue (May. 15) $3.70MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)Powered by Get Vivos Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vivos Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVVOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VVOS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Vivos Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.79) EPSNext Year EPS Consensus Estimate ($1.43) EPS Vivos Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025-$0.44-$0.45 -$0.01-$0.45$3.63M$3.70M3/27/2025Q4 2024-$0.43-$0.28+$0.15-$0.28$3.89M$3.70M8/14/2024Q2 2024--$0.60 -$0.60-$0.60-$4.05M5/14/2024Q1 2024--$1.63 -$1.63-$1.63-$3.42M3/28/2024Q4 2023--$3.05 -$3.05-$3.05-$3.25M11/14/2023Q3 2023--$1.75 -$1.75-$1.75-$3.30M8/16/2023Q2 2023-$3.75-$3.75--$0.12$3.93M$3.40M6/8/2023Q1 2023-$4.25-$5.00 -$0.75-$0.33$3.71M$3.86M Vivos Therapeutics Earnings - Frequently Asked Questions When did Vivos Therapeutics announce their last quarterly earnings? Vivos Therapeutics (NASDAQ:VVOS) last announced its quarterly earning data on Thursday, May 15, 2025. Learn more on VVOS's earnings history. Did Vivos Therapeutics beat their earnings estimates last quarter? In the previous quarter, Vivos Therapeutics (NASDAQ:VVOS) missed the analysts' consensus estimate of ($0.44) by $0.01 with a reported earnings per share (EPS) of ($0.45). Learn more on analysts' earnings estimate vs. VVOS's actual earnings. How can I listen to Vivos Therapeutics's earnings conference call? The conference call for Vivos Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Vivos Therapeutics's conference call transcript? The conference call transcript for Vivos Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Vivos Therapeutics generate each year? Vivos Therapeutics (NASDAQ:VVOS) has a recorded annual revenue of $15.03 million. How much profit does Vivos Therapeutics generate each year? Vivos Therapeutics (NASDAQ:VVOS) has a recorded net income of -$13.58 million. VVOS has generated -$1.73 earnings per share over the last four quarters. What is Vivos Therapeutics's EPS forecast for next year? Vivos Therapeutics's earnings are expected to grow from ($1.79) per share to ($1.43) per share in the next year. More Earnings Resources from MarketBeat Related Companies MLSS Earnings Date INO Earnings Date NTRB Earnings Date ZYXI Earnings Date VANI Earnings Date OM Earnings Date HYPR Earnings Date SURG Earnings Date CTSO Earnings Date ICCM Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:VVOS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VVOS Stock Free VVOS Stock Alerts